These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 318672)

  • 41. Variability in the intradermal and in vitro lymphocyte responses to PPD in patients receiving isoniazid chemoprophylaxis.
    Tager IB; Kalaidjian R; Baldini L; Rocklin RE
    Am Rev Respir Dis; 1985 Feb; 131(2):214-20. PubMed ID: 3882032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tuberculin-induced lymphocyte transformation and skin reactivity in monkeys vaccinated or not vaccinated with Bacille Calmette-Guérin, then challenged with virulent Mycobacterium tuberculosis.
    Chaparas SD; Good RC; Janicki BW
    Am Rev Respir Dis; 1975 Jul; 112(1):43-7. PubMed ID: 807141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity.
    Geczy CL; Meyer PA
    J Immunol; 1982 Jan; 128(1):331-6. PubMed ID: 6172485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Counter inhibitor: a low molecular weight cytokine derived from human leukocyte dialysates reverses antigen dependent PMN and macrophage migration inhibition.
    Farmer JL; Rosenberg JS; Hester RB; Gottlieb AA
    Int Arch Allergy Appl Immunol; 1984; 73(2):146-50. PubMed ID: 6363305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dialyzable transfer factor in the treatment of human osteosarcoma: an analytic review.
    Fudenberg HH
    Ann N Y Acad Sci; 1976; 277(00):545-57. PubMed ID: 793487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B; Wätzig V; Knöll B
    Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro properties of leukocyte dialysates containing transfer factor.
    Ascher MS; Schneider WJ; Valentine FT; Lawrence HS
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1178-82. PubMed ID: 4524630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An unusual episode of lupus vulgaris masquerading as sporotrichosis.
    Khandpur S; Nanda S; Reddy BS
    Int J Dermatol; 2001 May; 40(5):336-9. PubMed ID: 11554997
    [No Abstract]   [Full Text] [Related]  

  • 49. The agarose migration inhibition technique for in vitro demonstration of cell-mediated immunity in man. A review.
    Clausen JE
    Dan Med Bull; 1975 Jul; 22(5):181-94. PubMed ID: 126141
    [No Abstract]   [Full Text] [Related]  

  • 50. Preoperative cell-mediated immune status of gastric cancer patients.
    Orita K; Miwa H; Fukuda H; Yumura M; Uchida Y
    Cancer; 1976 Dec; 38(6):2343-8. PubMed ID: 793709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lupus vulgaris. An unusual fungating and ulcerated form in a black South African.
    Dogliotti M; Leibowitz M; Smith E
    Int J Dermatol; 1979 Nov; 18(9):749-50. PubMed ID: 389848
    [No Abstract]   [Full Text] [Related]  

  • 52. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transfer factor in chronic and recurrent respiratory tract infections in children.
    Gröhn P
    Acta Paediatr Scand; 1977 Mar; 66(2):211-7. PubMed ID: 320816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of transfer factor in patients with advanced cancer.
    Krown SE; Pinsky CM; Hirshaut Y; Hansen JA; Oettgen HF
    Isr J Med Sci; 1978 Oct; 14(10):1026-38. PubMed ID: 310813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct components in dialyzable leukocyte extracts (DLE) have specific and nonspecific effects on cellular immunity as shown by leukocyte migration inhibition.
    Wilson GB; Fudenberg HH; Bahm VJ
    Trans Assoc Am Physicians; 1978; 91():295-332. PubMed ID: 754397
    [No Abstract]   [Full Text] [Related]  

  • 56. Lupus murinus. The discovery, diagnosis and treatment of seventeen cases of lupus murinus.
    Maguire A
    Br J Dermatol; 1968 Jul; 80(7):419-23. PubMed ID: 5665266
    [No Abstract]   [Full Text] [Related]  

  • 57. The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response.
    Gottlieb AA; Maziarz GA; Tamaki N; Sutcliffe SB
    J Immunol; 1980 Feb; 124(2):885-92. PubMed ID: 7356716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of transfer factor on the in vitro migration of tuberculin stimulated white cells from sarcoid and normal subjects.
    Park JR; De Bats A; Rhodes EL
    Br J Dermatol; 1975 May; 92(5):535-40. PubMed ID: 1174466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An investigation into the antigen-specificity of transfer factor in its stimulatory action on lymphocyte transformation.
    Salaman MR
    Immunology; 1978 Aug; 35(2):247-56. PubMed ID: 86502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic mucocutaneous candidiasis accompanied by enhanced antibody production.
    Takeya K; Nomoto K; Matsumoto T; Miyake T; Himeno K
    Clin Exp Immunol; 1976 Sep; 25(3):497-500. PubMed ID: 786522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.